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Loss of Amplified Genes by PoIy(ADP-
ribose) Polymerase Inhibitors
by Minako Nagao,* Michie Nakayasu,* Shizu Aonuma,*
Hiroshi Shima,* and Takashi Sugimura*
A poly(ADP-ribose) polymerase inhibitor, benzamide (BA), was found to induce flat revertants of NIH
3T3 cells that had been transformed by human Ha-ras, rat Ki-ras, rat c-raf, and human ret-Il. These genes
had been amplified in original transformants, but they were completely eliminated by BA. Contrary to
this, endogenous activated Ha-ras in a human bladder carcinoma cell line, T24, was not eliminated by
BA. The gene loss seemed to be restricted to exogenous and/or amplified sequences. BA also eliminated
the amplified c-myc gene in HL-60 cells, concomitant with differentiation into granulocytes. We dem-
onstrated that the amplified c-myc gene was not present as episomes. It is probably present as double
minutes or a homogeneously staining region. Dimethylsulfoxide also induced differentiation at a concen-
tration that did not inhibit poly(ADP-ribose) polymerase. The cell lost the c-myc gene in association with
this differentiation. The amplified c-myc gene in a colon adenocarcinoma cell line, COLO 320HSR, and
the amplified mdr-1 gene in an adriamycin-resistant myelogenous leukemia cell line, K562/ADM, were not
eliminated by BA. Various poly(ADP-ribose) polymerase inhibitors also eliminated human Ha-ras in the
NIH 3T3 transformant and the c-myc gene in HL-60 cells.
Introduction
Carcinogenesis is a multistep process involving mu-
tation, amplification, loss, and rearrangement of genes.
Oncogene amplification is often associated with malig-
nant progression. For instance, amplification of the c-
myc gene is often observed in advanced cases ofuterus
cervical cancer (1) and advanced cases of breast cancer
(2), while amplification of N-myc is often observed in
advanced cases of neuroblastoma (3). Recently, we
found that poly(ADP-ribose) polymerase inhibitors
eliminated the exogenous amplified sequence in NIH
3T3 transformants (4).
Poly(ADP-ribose) polymerase [ADP-ribosyltransfer-
ase(polymerizing); EC 2.4.2.30] modifies a number of
proteins by transferring the ADP-ribose moiety of nic-
otinamide adenine dinucleotide (NAD) to the protein
and polymerizing it (5,6). Inhibitors of poly(ADP-ri-
bose) polymerase such as benzamide (BA) and 3-ami-
nobenzamide are potent inducers of sister chromatid
exchanges (7). These inhibitors also inhibit DNA rep-
lication, causing concomitant accumulation of nascent
10 kb DNA (8), inhibition of DNA repair (9), and mod-
ulation of cell differentiation (10-12). 3-Aminobenza-
mide has been shown to enhance alkylating agent-in-
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duced amplification of SV-40 DNA integrated into
cellular DNA of the host (13). Recently, a mutant of
Chinese hamster V79 cells with very low poly(ADP-
ribose) polymerase activity was isolated and shown to
be a slow grower, to be sensitive to alkylating agents,
and to have a much higher background level of sister
chromatid exchanges than the parental V79 cells (14).
These findings show that poly(ADP-ribose) polymerase
is involved in DNA repair and suppression of sister
chromatid exchanges.
In this study, we examined the effects of poly(ADP-
ribose) polymerase inhibitors on amplified genes using
several NIH 3T3 transformants harboring different on-
cogenes: a human promyelocytic leukemic cell line, HL-
60, in which endogenous c-myc is amplified, a human
colon carcinoma cell line, COLO 320HSR, in which c-
myc is amplified as a homogeneously staining region
(HSR), and a human myelogenous leukemic cell line,
K562/ADM, in which the mdr-1 gene is amplified.
Results
Elimination of Exogenous Transforming
Genes
al-1 Cells are a secondary transformant of NIH 3T3
cells retaining c-Ha-ras'4 of the T24 human bladder
carcinoma cell line. When these cells were cultured in
the presence of 5 mM BA, with cell transfer every 4 to
5 days, most cells became flat after 2 to 4 weeks. OnNAGAO ET AL.
Southern blot analysis using the v-Ha-ras DNA frag-
ment (BS-9) as a probe, the intensity of hybridization
of the human c-Ha-ras sequence in al-1 cells was four
times that ofthe endogenous mouse c-Ha-ras sequence.
Its hybridizationintensity did notchange duringculture
for 4 weeks in the absence ofbenzamide. Addition of 5
mM benzamide to the medium did not change the hy-
bridizationintensity ofendogenous mousec-Ha-ras, but
specifically reduced that ofthe exogenous ras sequence
(Fig. 1). These results indicated that flat reversion of
al-1 cells was due to loss ofthe exogenous transforming
gene. There are two possible explanations forthe effect
ofBA; one is that BA might cause selection offlat cells
that were induced spontaneously, and the other is that
BA might cause specific elimination of the exogenous
transforming gene. To clarify the action of BA, we ex-
amined its effect on al-1 cells without cell transfer.
al-1 Cells were plated at a density of 30 cells/10 cm
diameter Petri dish, BA was added on day 2, and the
cultures were maintained for 2 weeks. The cell mor-
phology ofthe colonies was then examined. Each colony
was found to contain many clusters of flat revertants
surrounded by transformed cells (Fig. 2), indicating the
induction, but not the selection, of flat cells.
By cloningthese cells, five clones each oftransformed
cells and flat cells were obtained. Southern blotting
showed that all five clones of flat cells had lost the ac-
tivated human c-Ha-ras sequence, whereas all five
clones of transformed cells still retained whole copies
of activated human c-Ha-ras. No change of the endog-
enous mouse c-Ha-ras gene was observed in these 10
clones. We also found that BA had no effect on the
human c-Ha-rasT24 sequence in T24 cells, in which it
exists as a nonamplified homozygous sequence. There-
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FIGURE 1. Decrease ofhuman c-Ha-rasT4 sequence in al-1 cells by
treatment with benzamide. A clone of al-1 cells was cultured in
the presence of 5 mM benzamide for the indicated periods with
cell transfer every 4 to 5 days. The hybridization intensity ob-
served on Southern blotting of BamHI digests of cellular DNA
with the BS9 fragment of v-Ha-ras as probe is expressed as a
ratio to that of the endogenous mouse c-Ha-ras sequence, which
was constant.
FIGURE 2. Induction offlat cells on treatment with benzamide. Cell
morphology of a al-i cell colony grown in the presence of 5 mM
benzamide is shown. Arrows show clusters offlat revertant cells.
fore, we conclude that BA caused elimination of exog-
enous and/or amplified sequences.
Poly(ADP-ribose) polymerase is composed of three
domains, NAD binding, automodification, and DNA-
binding domains (6) and has two contiguous zinc-finger
structures (15). Not only BA, a competitor with sub-
strate NAD, but also the DNA site inhibitor, coumarin
(4), and a newly found potent inhibitor, luminol (4),
induced flat revertants efficiently (Table 1). On the con-
trary, noninhibitory analogues of BA, benzoic acid and
3-aminobenzoic acid did not induce flat revertants ofal-
1 cells. Thus, elimination of exogenous amplified se-
quences seems to be an intrinsic property ofpoly(ADP-
ribose) polymerase inhibitors.
Other transfected genes such as activated Ki-ras, N-
ras, c-raf, and ret-II were also very efficiently elimi-
nated by culturing the transformants in the presence of
5 mM BA for 2 weeks (4), and these BA-treated cells
were also flattened. These activated oncogenes were of
rat (Ki-ras) or human (N-ras, c-raf and ret-II) origin;
that is, they were derived from a different species from
the host cells.
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Table 1. Flat cell induction by poly(ADP-ribose) polymerase inhibitors.a
Morphology of colony, %
Compound Application, mM A B C Plating efficiency, %
Benzamide 5.0 8.2 27.4 64.4 27.0
3-Aminobenzamide 5.0 65.8 17.1 17.1 54.1
Coumarin 2.5 13.2 47.3 39.6 33.7
Luminol 1.0 4.4 16.8 78.8 41.9
Benzoic acid 1.0 89.0 3.6 7.3 20.4
2.5 100 0 0 1.9
3-Aminobenzoic acid 5.0 68.4 28.4 3.2 35.2
Untreated 94.3 3.9 1.8 83.9
'A clone ofal-I cells was plated at a density ofabout 90 cells per 10-cm Petri dish and treated with the above compounds for 12 days. Colonies
were fixed in methanol and stained with Giemsa's solution. Then they were classified as type A, B, or C by microscopic examination. Type A,
a colony composed ofonly transformed cells; B, a colony composed ofless than 50% offlat cells; C, a colony composed ofmore than 50% offlat
cells. Average values for three plates are shown.
Elimination of Amplified Endogenous
Gene
To determine the effects of poly(ADP-ribose) poly-
merase inhibitors on an amplified endogenous sequence,
we examined their effects on the c-myc gene in HL-60
cells, a human promyelocytic cell line. The human c-
myc gene is amplified about 16-fold in our stock of HL-
60cells. WhenHL-60cellswereculturedinthepresence
of7.5 mM BA, they differentiated into granulocytes, as
reported previously (16). Cell differentiation was de-
termined by examination of nitroblue tetrazolium re-
ducing activity in the presence ofphorbol 12-myristate
13-acetate (PMA). As shown in Figure 3, the cells did
not grow after differentiation. Scarcely any ofthe cells
reduced nitroblue tetrazolium on day 2, but on day 3
after addition ofBA, more than 60% ofthe cells showed
nitroblue tetrazolium reducing activity and appeared
granulocytic with segmented nuclei. Treatments with
coumarin and 4-hydroxyquinazoline, a newly found po-
tent inhibitor (17), at concentrations of 2.5 mM also
induced granulocytic differentiation of the cells after 3
days.
Southern blot analysis showed that the c-myc gene
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was lost concomitantly with differentiation of the cells
on treatment with BA (Fig. 3) and various other
poly(ADP-ribose) polymerase inhibitors (17). A nonin-
hibitory analogue of BA, benzoic acid, did not induce
either cell differentiation or gene loss (data not shown).
We also examined the effect of dimethyl sulfoxide
(DMSO), a well-known granulocytic inducer, on c-myc
gene loss. With 1.6% DMSO, morphologicalchangesand
gene loss were observed on day 3 (Fig. 3). DMSO has
been found to inhibit poly(ADP-ribose) polymerase in
vitro at concentrations of the substrate, NAD, of less
than 25 nM, but tocause only slightinhibition at cellular
concentrations of NAD (K. Ueda, personal communi-
cation), which are in the order of several hundred mi-
cromolar (18,19). Thus, the mechanism of induction of
cell differentiation and gene loss by DMSO is not yet
known.
Recently, theamplified c-mycgeneinHL-60cellswas
reported to be present as an episomal element about
250 kb in size at early passages ofthe HL-60 cells (20).
This episomal element can enteragarose on pulsed-field
gradient gel electrophoresis (PFGE) (21). Therefore,
for determination ofthe state ofthe c-myc gene in our
stockofHL-60cells, thecellswereembeddedinagarose
Time in culture (days)
FIGURE 3. Effects of BA and DMSO on HL-60 cells. (Left panel) Cell growth. (Middle panel) Differentiation into granulocytes determined
from the nitroblue tetrazolium (NBT) reducing activity. (Right panel) Hybridization intensity ofthe c-myc gene by Southern blot analysis.
(0-) With 7.5 mM BA; (A-A) with 1.6% DMSO; (0-0) with no addition.
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and lysed with sodium N-lauroylsarcosinate, and the
uncut DNA was separated by PFGE as described (21).
Results showed that the amplified c-myc gene in our
stock of HL-60 cells was not present as episomes, but
possibly present as double minutes (DMs) or a homo-
geneously staining region (HSR). The HL-60 cells dif-
ferentiate into macrophages on treatment with PMA or
teleocidin, but this differentiation was not associated
with gene loss.
Effect of BA on the Amplified c-myc Gene
in COLO 320 Cells
We also examined the effect ofpoly(ADP-ribose) po-
lymerase inhibitors on the amplified c-myc gene in
COLO 320HSR cells. These cells were derived from a
human colonadenocarcinoma (22), andinduction oftheir
terminal differentiation in vitro by poly(ADP-ribose)
polymerase inhibitors has so far not been reported.
COLO 320 HSR cells were obtained from the American
Type Culture Collection (Rockville, Maryland), and a
clone was isolated by limiting dilution. A 75-cm2 flask
was coated with collagen type 1 by adding 7.5 mL of a
solution of collagen type 1 (300 ,ug/mL), standing the
flask for 1 hr at room temperature, and then washing
it twice with phosphate-buffered saline. About 800 cells
of the clone were then inoculated into the flask and
cultured in 9 mL ofRPMI-1640 medium containing 10%
fetal calf serum and 5 mM BA for 12 days.
Under these conditions, cell growth was reduced to
about 50% of that in control cultures. In the presence
of5 mM BA, more than 50% ofthe cells became tightly
adherent tothe substrate, whereasonly afewcellswere
loosely adherent in the absence of BA (Fig. 4). These
adherent cells in cultures with benzamide were flat,
clearly differing in morphology from cells in control cul-
tures. Nonadherent cellsincultureswith5mMBAwere
removed by pipette with vigorous shaking to separate
them from adherent cells, and the DNAs ofthese non-
adherent and adherent cells and also ofuntreated cells
were extracted. Southern blot analysis indicated that
the hybridization intensity ofc-myc was not changed in
these flat cells. Thus, the change of cell morphology
induced by BA was not associated with loss ofthe am-
plified c-myc gene.
When the cells were cultured in uncoated flasks, they
grew in suspension. Additions ofhigh concentrations of
polymerase inhibitors, 5 mM 4-hydroxyquinazoline or
12.5 mM BA, inhibited cell growth almost completely,
but no loss of the c-myc gene was found after 20 days
of treatment with either of these inhibitors. These re-
sults indicate thatthe amplified endogenous c-myc gene
is not necessarily eliminated by poly(ADP-ribose) po-
lymerase inhibitors.
Effect of BA on the Amplified mdr-1 Gene
in K562/ADM Cells
Serious problems in cancer therapy are resistance of
progressed cancer cells to chemotherapeutic agents and
the acquisition of resistance during treatment. We ex-
amined the effect of poly(ADP-ribose) polymerase in-
hibitors on the amplified mdr-1 gene induced by adri-
amycin treatment in myelogenous leukemia K562 cells,
K562/ADM (provided by T. Tsuruo, University of To-
kyo) (22). We isolated three clones ofK562/ADM, K562/
ADM-1, K562/ADM-2, and K562/ADM-3, and two
clones ofK562, K562-1 and K562-2. Southernblotanaly-
sis ofdigest ofthese DNAs withHindIII, usingpMDR1
(provided by I. B. Roninson, University of Illinois) as
a probe indicated that K562/ADM-1-3 have an ampli-
fied mdr-1 gene, as shownin Figure 5. Whenthese cells
were treated with various concentrations of BA, their
growth rates were reduced dose dependently, about
50% growth inhibition being observed with 5 mM BA.
This dose-dependent inhibition of cell growth by BA
suggests that BA was taken up into these cells in spite
of the presence of the amplified mdr-1 gene. Figure 5
shows that there was no loss of the mdr-1 gene even
after culture for 5 weeks in the presence of 5 mM BA.
Discussion
Poly(ADP-ribose) polymerase inhibitors were found
to eliminate exogenous and amplified sequences effi-
ciently. In this study, we used transformants harboring
oncogenes that were amplified and were derived from
a different species from the host cells. Thus, we suspect
that poly(ADP-ribose) polymerase may have some
mechanismtorecognize speciesdifferences ofDNAand/
or amplified sequences. But we have no information on
the problem ofrecognition ofdifferent species ofDNAs
because we have not yet examined the effect of BA on
transfected mouse sequences in NIH 3T3 cells.
We tried to analyze the status of transfected se-
quences in NIH 3T3 cells by in situ hybridization, but
thiswasnot successfulbecause oftheinstabilityofkary-
otypes of the NIH 3T3 cells. Thus, we do not know if
the exogenous amplified sequences are present as dou-
ble minutes, integrated into a chromosome, or as epi-
somes.
To characterize the gene eliminating activity of
poly(ADP-ribose) polymerase inhibitors, we focused at-
tention on amplified sequences. We chose HL-60 cells,
a hematopoietic cell line with amplified c-myc that is
known to differentiate into granulocytes on treatment
with poly(ADP-ribose) polymerase inhibitors. We also
examined the effect ofpolymerase inhibitors on COLO
320HSR, which is an epithelial cell line in which the
status of amplified c-myc has been determined (21).
Thirdly, we used K562/ADM, a hematopoietic cell line
in which a nononcogenic gene, mdr-1, is known to be
amplified, but the effect ofpolymerase inhibitors on cell
differentiation was unknown.
In the HL-60 cells used in this study, the c-myc gene
was found not to be present as episomes, but probably
as DMs or HSR (on chromosome 8). The c-myc gene
was eliminatedbytreatment with poly(ADP-ribose) po-
lymerase inhibitors. It is unknown, however, whether
polymerase inhibitors eliminated all the c-myc genes in
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FIGURE 4. Effect of BA on COLO 320HSR. Inocula of 800 cells of a COLO 320HSR clone were cultured for 12 days in flasks coated with
collagen type 1 with no addition (A) or with 5 mM BA (B). Nonadherent cells in the culture with 5 mM BA were separated from adherent
cells by pipette. (C) Southern blot analysis was performed onXbaI digests ofDNA from untreated cells (lane 1) and BA treated nonadherent
(lane 2) and adherent (lane 3) cells with the PstI-PstI fragment of human MYC as probe.
4'aK562/ADM-1 K5621ADM-2 K562/ADM-3
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FIGURE 5. Effect of BA on the amplified mdr-1 gene in K562/ADM
cells. Clones K562/ADM-1, K562/ADM-2, and K562/ADM-3 were
cultured in the presence of 5 mM BA for the indicated periods.
Southernblotanalysis wasperformed onHindIII digests ofDNAs
using a human mdr-1 gene fragment, pMDR-1, as a probe.
differentiated cells or only reduced their copy number
per cell. HL-60 cells differentiated into granulocytes
and did not grow any more after granulocytic differ-
entiation. Therefore, in situ hybridization will be nec-
essary to determine whether the differentiated cells
contain any copies of the c-myc gene. Gene loss was
also observed on treatment with DMSO. The mecha-
nism of induction of differentiation of HL-60 cells by
DMSO has not been fully elucidated. As described in
the text, DMSO at a concentration of 1.6% probably
does not inhibit poly(ADP-ribose) polymerase. We are
nowmeasuringthe amounts ofpoly(ADP-ribose) in HL-
60 cells treated with BA or DMSO using an antibody
against poly(ADP-ribose) to determine whether these
compounds inhibit the poly(ADP-ribosyl)ation reaction
in vivo. We are also examining whether other types of
granulocytic inducers also cause loss ofthe c-myc gene.
We also used another cell line, COLO 320HSR, in
which the amplified c-myc gene has been shown to be
present as HSR on chromosome X. BA induced mor-
phological changes of these cells but not c-myc gene
loss. From these findings, two possibilities can be con-
sidered. One is that the c-myc gene in the HL-60 cells
used in this study is present as DMs, and the sequence
on DMs can be eliminated by poly(ADP-ribose) poly-
merase inhibitors. The otheris that loss ofthe amplified
endogenous c-myc is associated with granulocytic cell
differentiation, which is associated with segmentation
of the nuclei.
Another amplified endogenous gene, mdr-1, in K562/
ADM, was not eliminated by poly(ADP-ribose) poly-
merase inhibitors. From these results we conclude that
certain conditions are necessary for elimination of am-
plified endogenous genes by poly(ADP-ribose) poly-
merase inhibitors. We are now examining the effect of
poly(ADP-ribose) polymerase inhibitors on integrated
viral sequences to determine whether these exogenous
sequences can be eliminated by poly(ADP-ribose) po-
lymerase inhibitors.
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